Moreover, obesity has been shown to impair the efficacy of psoriasis treatments, particularly fixed-dose biologics like TNF inhibitors, likely due to altered pharmacokinetics and increased systemic inflammation [9]. The gene discussed is TNF; the disease is obesity disorder.